JPRN-UMIN000047044尚未招募未知
sefulness of postoperative adjuvant chemotherapy in patients with colorectal cancer T1/T2, N(+) - Usefulness of postoperative adjuvant chemotherapy in patients with colorectal cancer T1/T2, N(+)
Japanese Foundation for Multidisciplinary Treatment of Cancer0 个研究点目标入组 621 人开始时间: 2022年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 621
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Safety and efficacy of postoperative adjuvant chemotherapy with L-OHP base regimen followed by UFT plus LV for resectable liver metastases from colorectal cancerresectable liver metastases from colorectal cancerJPRN-UMIN000020631Kyoto University50
已完成
不适用
OFT trialColorectal liver metastasisCRLM, FOLFOXJPRN-jRCT1051190106Hatano Etsuro50
进行中（未招募）
1 期
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
已完成
3 期
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
尚未招募
不适用
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastasesColorectal liver metastases, clinical risk score, high risk patients, colorectale levermetastasen, klinische risico score, hoog risico patientenNL-OMON27498Prof. Dr. C. VerhoefErasmus MC Cancer Institute224